CureVac N.V.

CVACNASDAQHealthcare

$4.66

+$0.00(+0.00%)

Market Cap$1.0B

P/E Ratio—

52W High$5.72

52W Low$2.475

Avg Volume1.2M

Open$4.57

Beta1.84

Net Income Financials Revenue

CureVac N.V. (CVAC) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CVAC · net income · updated Jun 8, 2026

Core profitability metrics

CVAC · net income · margin · TTM · CAGR

Net income was $162.2M for FY2024 (fiscal year ending 2024-12-31), up 162.3% year-over-year. Net profit margin was 30.3%. Based on available data, CureVac N.V. has been profitable since at least 2024.

FY2024 Net Income$162.2M▲ +162.3% YoY

Trailing 12M (TTM)$128.8Mtrailing 4 quarters sum

Net Profit Margin30.3%$162.2M ÷ $535.2M

YoY Change+162.3%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2024

▸ FMP /income-statement · Annual · CVAC net income history · CVAC profit margin

Annual net income data

CVAC · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2024★ First Profit$162.2M▲ +162.3%30.3%$535.2M

FY2023Loss−$260.2M▼ 4.5%-484.0%$53.8M

FY2022Loss−$249.0M▲ +39.5%-369.4%$67.4M

FY2021Loss−$411.7M▼ 219.0%-399.8%$103.0M

FY2020Loss−$129.1M▼ 29.2%-264.0%$48.9M

Net income vs peers (Healthcare)

CVAC vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

CureVac N.V.YOU

CVAC

$162.2M+162.3%30.3%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

CureVac N.V. (CVAC) reported net income of $162.2M for FY2024 (fiscal year ending 2024-12-31), up 162.3% year-over-year. The net profit margin was 30.3% — meaning the company kept $0.30 of every dollar of revenue as profit.

Based on available data, CureVac N.V. has been profitable since at least 2024. Net income reached a peak of $162.2M in FY2024. Data available for 7 fiscal years.

CureVac N.V.'s net profit margin was 30.3% for FY2024, based on the latest annual results.

Investors sometimes search for "CureVac N.V. net worth" — the company's market capitalization is a separate figure from CVAC net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CVAC net income · 5 questions

CureVac N.V. is profitable. The company reported net income of $162.2M for FY2024, a net profit margin of 30.3%. Net income was up 162.3% year-over-year. Based on available data, CureVac N.V. has been profitable since at least 2024.

is CVAC profitabledoes CVAC make a profitCVAC profitabilityCVAC profitable company

▸ Source: FMP /income-statement · GAAP · CureVac N.V. · CureVac N.V. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026